Research programme: small molecule therapeutics - Morphic Therapeutic
Alternative Names: αvβ8 programmeLatest Information Update: 27 Apr 2023
At a glance
- Originator Morphic Therapeutic
- Class Antineoplastics; Small molecules
- Mechanism of Action Integrin alphavbeta8 inhibitors; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
- Research Myelofibrosis
Most Recent Events
- 25 Apr 2023 Early research in Myelofibrosis in USA (unspecified route)
- 15 Nov 2021 Pharmacodynamics data from a preclinical studies in Solid tumors presented at the SITC Annual Meeting
- 12 Apr 2021 Pharmacodynamics data from a preclinical trial in Solid tumours presented at the American Association for Cancer Research Annual Meeting (AACR-2021)